Skip to main content

A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study.

Publication ,  Conference
Lyerly, HK; Hobeika, A; Niedzwiecki, D; Osada, T; Marshall, J; Garrett, CR; Chang, DZ; Aklilu, M; Crocenzi, TS; Cole, DJ; Dessureault, S ...
Published in: Journal of Clinical Oncology
May 20, 2011

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2011

Volume

29

Issue

15_suppl

Start / End Page

2533 / 2533

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lyerly, H. K., Hobeika, A., Niedzwiecki, D., Osada, T., Marshall, J., Garrett, C. R., … Morse, M. (2011). A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study. In Journal of Clinical Oncology (Vol. 29, pp. 2533–2533). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2011.29.15_suppl.2533
Lyerly, H. K., A. Hobeika, D. Niedzwiecki, T. Osada, J. Marshall, C. R. Garrett, D. Z. Chang, et al. “A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study.” In Journal of Clinical Oncology, 29:2533–2533. American Society of Clinical Oncology (ASCO), 2011. https://doi.org/10.1200/jco.2011.29.15_suppl.2533.
Lyerly HK, Hobeika A, Niedzwiecki D, Osada T, Marshall J, Garrett CR, et al. A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011. p. 2533–2533.
Lyerly, H. K., et al. “A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study.Journal of Clinical Oncology, vol. 29, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2011, pp. 2533–2533. Crossref, doi:10.1200/jco.2011.29.15_suppl.2533.
Lyerly HK, Hobeika A, Niedzwiecki D, Osada T, Marshall J, Garrett CR, Chang DZ, Aklilu M, Crocenzi TS, Cole DJ, Dessureault S, Hsu SD, Bulusu A, Clary BM, Annechiarico R, Devi G, Chadaram V, Clay TM, Morse M. A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011. p. 2533–2533.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2011

Volume

29

Issue

15_suppl

Start / End Page

2533 / 2533

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences